Latest John McDonald Stories
New software key for personalized cancer medicine High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients. The real revolution, however, is coming with the emerging capability to inexpensively and accurately sequence the entire genome of cancers, allowing for the...
For years, scientists believed the vast phenotypic differences between humans and chimpanzees would be easily explained – the two species must have significantly different genetic makeups. However, when their genomes were later sequenced, researchers were surprised to learn that the DNA sequences of human and chimpanzee genes are nearly identical. What then is responsible for the many morphological and behavioral differences between the two species? Researchers at the Georgia Institute of...
NEW YORK, June 10, 2011 /PRNewswire/ -- George T. McDonald, Founder and President of The Doe Fund, announced a series of management changes designed to position the 25-year old organization for its next phase of development. "For over two decades, John McDonald has proved his worth to The Doe Fund and to the individuals we serve. Leaving a lucrative career in the finance industry, he joined The Doe Fund as our Chief Financial Officer in 1990, and has worked tirelessly to ensure that our...
Magnetic nanoparticlesA paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option "“ one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.Researchers at the Georgia Institute of Technology have formed a startup company and are working with a medical device firm to design a prototype treatment system that would use...
Electronic biosensing technology could facilitate new era of personalized medicineWriter: John Toon, Georgia Institute of TechnologyThe multi-welled microplate, long a standard tool in biomedical research and diagnostic laboratories, could become a thing of the past thanks to new electronic biosensing technology developed by a team of microelectronics engineers and biomedical scientists at the Georgia Institute of Technology.Essentially arrays of tiny test tubes, microplates have been used...
Scientists at Georgia Tech and the Ovarian Cancer Institute have further developed a potential new treatment against cancer that uses magnetic nanoparticles to attach to cancer cells, removing them from the body. The treatment, tested in mice in 2008, has now been tested using samples from human cancer patients. The results appear online in the journal Nanomedicine."We are primarily interested in developing an effective method to reduce the spread of ovarian cancer cells to other organs ,"...
Casey Janssen began a four-inning scoreless stretch by the Toronto bullpen Wednesday in the Blue Jays' 7-3 victory over Baltimore. Toronto overcame an early 2-0 deficit to win its third straight game. Scott Richmond (7-10) left the game after five innings with a 4-3 lead and got the win thanks to outstanding relief pitching from Janssen, Josh Roenicke, Brandon League and Jason Frasor. The relievers combined to give up a hit and one walk. The Blue Jays broke a 2-2 tie with a three-run...
